Expression of Telomerase Activity in Experimental Cholesteatoma

ABSTRACT Background and Objectoves:Telomerase is a marker of cell proliferation in malignant tissues and also can be expressed in benign disease such as cholesteatoma. There are two opposite opinions about the expression of telomerase in cholesteatoma. The purpose of this study is to evaluate whether telomerase is expressed in expreimentally induced cholesteatoma. Materials and Methods:Cholesteatoma was induced by ligation of EAC of ten Mongolian gerbils. The telomerase activity was detected by the telomerase repeat amplification protocol (TRAP) assay method in both cholesteatoma and normal control retroauricular skin. Results:10 of 10 (100%) cholesteatoma cases expressed telomerase activity, whereas 3 of 10 (30%) retroauricular normal skin detected telomerase activity. Conclusions:The high expression of telomerase in experimentally induced cholesteatoma suggests activation of telomerase may be related to the proliferative nature of cholesteatoma as in human tissues. (J Clinical Otolaryngol 2004;15:250-255)

[1]  M. Sittinger,et al.  Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma , 2004, European Archives of Oto-Rhino-Laryngology.

[2]  T. Lenarz,et al.  Telomerase Activity, Telomere Length, and Apoptosis: A Comparison between Acquired Cholesteatoma and Squamous Cell Carcinoma , 2002, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[3]  K. Chon,et al.  Expression of telomerase activity in cholesteatoma otitis media , 2001, The Journal of Laryngology & Otology.

[4]  H. Kojima,et al.  Molecular Biological Diagnosis of Congenital and Acquired Cholesteatoma on the Basis of Differences in Telomere Length , 2001, The Laryngoscope.

[5]  Y. Choung,et al.  Mechanism of Apoptotic Cell Death in Cholesteatoma Epithelium , 1998 .

[6]  M. Droller Telomerase activity: a biomarker of cell proliferation, not malignant transformation. , 1998, The Journal of urology.

[7]  S. Kannan,et al.  Telomerase activity in premalignant and malignant lesions of human oral mucosa. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  R. Dahse,et al.  Telomeres and telomerase: biological and clinical importance. , 1997, Clinical chemistry.

[9]  S. Kyo,et al.  Telomerase activity in human endometrium. , 1997, Cancer research.

[10]  C. Park,et al.  Experimental Study on TGF-β 1 Gene Expression in Cholesteatoma , 1997 .

[11]  A. Sakuntabhai,et al.  Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. , 1996, Cancer research.

[12]  Cheng-chun Huang,et al.  Expressions of c‐jun and p53 proteins in human middle ear cholesteatoma: Relationship to keratinocyte proliferation, differentiation, and programmed cell death , 1995, The Laryngoscope.

[13]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[14]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[15]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[16]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.